The trend of commission-free online trading platforms makes investing more accessible to more people, especially as account minimums disappear. It's important to understand that when an online broker ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Stella Osoba is the Senior Editor of trading and investing at Investopedia. She co-founded and chaired Women in Technical Analysis. She has 15+ years of experience as a financial writer and technical ...

Many people interested in trading stocks wonder if there are any rules about when to buy or sell stocks. While some vague timing guidelines do exist, the best time to buy or sell a stock really ...

ChatGPT predicts XRP at $6-$8 if ETFs hit $10B. Claude predicts $8-$14. Analysts target $5-$6. Here's why the XRP forecasts ...

Day trading might sound like a fun way to make a living, but it’s a hard game for new traders to break into. Not only do day traders need high-tech stock scanners to locate stocks with potential, but ...

Chris Davis is a Managing Editor on the Investing team. As a writer, he covered the stock market, investing strategies and investment accounts, and as a spokesperson, he appeared on NBC Bay Area and ...

Up 80% YTD as ETFs surged despite 30% pullback from $126K peak. Here's what the year revealed about BTC maturity.

Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial consultant. She has a demonstrated ...

Welcome back! At Breakingviews we prefer to look forward rather than back. But in this edition, the last of 2025, I’ll recap ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. My ...